Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Paul A. Grayson Insider Profile
4 Followers
Paul A. Grayson , Director at Skye Bioscience, holds 259.70K shares in Skye Bioscience (Ticker: SKYE). Most recently, Paul A. Grayson Sold $86,551 shares of Skye Bioscience on Nov 19, 2024 for an estimated value of 432.06K.
Paul A. Grayson has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Paul A. Grayson 's holdings
Insider Roles
Director
Roles that Paul A. Grayson holds in companies
Most Profitable Insider Trade
The most profitable trade made by Paul A. Grayson
Paul A. Grayson 's Trading History
List of latest transactions for each holding click on a transaction to see Paul A. Grayson 's performance on stock
You May Also Like
Paul A. Grayson insider profile FAQ
What is the percentage of profitable transactions made by Paul A. Grayson ?
The percentage of profitable transactions made by Paul A. Grayson is ―.
What is the average return per transaction made by Paul A. Grayson ?
The average return per transaction made by Paul A. Grayson is ―.
What stocks does Paul A. Grayson hold?
Paul A. Grayson holds: SKYE stocks.
What was Paul A. Grayson ’s latest transaction?
Paul A. Grayson latest transaction was an Informative Sell of $432.06K.
What was Paul A. Grayson 's most profitable transaction?
Paul A. Grayson ’s most profitable transaction was an Informative Sell of SKYE stock on November 19, 2024. The return on the trade was 37.70%.
What is Paul A. Grayson 's role in Skye Bioscience?
Paul A. Grayson 's role in Skye Bioscience is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.